HCYTABA-17K

MILLIPLEX^® Human Cytokine Autoantibody Panel

Configurable Human Cytokine Autoantibody IgA 23-Plex Panel

• NACRES: NA.84
• UNSPSC Code: 12161503

Eigenschaften

• Produktname: MILLIPLEX^® Human Cytokine Autoantibody Panel,
• description: Configurable Human Cytokine Autoantibody IgA 23-Plex Panel
• Quality Segment: 200
• species reactivity: human
• packaging: pkg of 1 ea
• manufacturer/tradename: Milliplex^®
• technique(s): multiplexing: suitable
• input: plasma; serum
• detection method: fluorometric (Luminex^® xMAP^® technology)
• shipped in: wet ice
• storage temp.: 2-8°C

Beschreibung

General description

Anti-cytokine antibodies occur frequently and are present in healthy individuals and patients with acquired immunodeficiency and autoimmune diseases. Cytokines offering protection against microbes can be targeted by cytokine autoantibodies, leading to life-threatening infections. Some infections associated with anti-cytokine antibodies include M. tuberculosis, Salmonella, S. aureus. E. coli, Histoplasma, and more. The presence of cytokine autoantibodies in autoimmune disease can influence disease severity and activity. These autoimmune diseases may include systemic lupus erythematosus, multiple sclerosis, Sjögren′s syndrome, rheumatoid arthritis, and acute respiratory distress syndrome.

Application

MILLIPLEX^® Qualified assays undergo rigorous assay development, verification, and Quality Control testing to achieve optimal performance. Simultaneously analyze up to 23 analytes in human serum and plasma samples.

Analytes included: Anti-BAFF, Anti-G-CSF, Anti-IFNβ, Anti-IFNγ, Anti-IL-1α, Anti-IL-6, Anti IL 8, Anti-IL-10, Anti-IL-12p40, Anti-IL-15, Anti-IL-17A, Anti-IL-17F, Anti-IL-18, Anti-IL-22, Anti-TNFα, Anti-IFNα2, Anti-GM-CSF, Anti-IL-2, Anti-IL-3, Anti-IL-4, Anti-Osteopontin, Anti-PF4, and Anti-IFNψ

Note: This is a qualitative assay.

Assay Characteristics: Refer to kit protocol for assay cross-reactivity and precision.

Features and Benefits

• Multiplexing Advantage: Measure 23 cytokine autoantibodies in one assay.
• Complement to Systemic Analysis: Provide additional immune response perspective alongside IgG and IgM measurements for comprehensive autoantibody class profiling in research studies.
• Proven Specificity: All panels verified with no or negligible cross-reactivity between analytes, ensuring accurate identification of specific cytokine autoantibodies across all immunoglobulin classes.
• Advanced Technology Platform: Built on proven Luminex^® xMAP^® magnetic bead technology, delivering consistent performance across IgG, IgM, and IgA detection platforms.

Legal Information

Luminex is a registered trademark of Luminex Corporation

MILLIPLEX is a registered trademark of Merck KGaA, Darmstadt, Germany

xMAP is a registered trademark of Luminex Corp

Disclaimer

For research use only. Not for use in diagnostic procedures.

Label License/Sticker for Assay Product:

By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.

Sicherheitshinweise

• pictograms: GHS07,GHS09
• signalword: Warning
• hcodes: H317,H319,H411
• pcodes: P261 - P264 - P273 - P280 - P302 + P352 - P305 + P351 + P338
• Hazard Classifications: Aquatic Chronic 2 - Eye Irrit. 2 - Skin Sens. 1
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• Lagerklasse: 12 - Non Combustible Liquids